A model for treatment strategy in the chemotherapy of AIDS

From MaRDI portal
Publication:1915184

DOI10.1007/BF02458312zbMath0853.92009OpenAlexW4232201800MaRDI QIDQ1915184

Glenn F. Webb, Denise E. Kirschner

Publication date: 11 June 1996

Published in: Bulletin of Mathematical Biology (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1007/bf02458312




Related Items

FEEDBACK CONTROL OF THE CHEMOTHERAPY OF HIVShort and long period optimization of drug doses in the treatment of AIDSMathematical modeling and numerical simulation of HIV infection modelAn HIV infection model based on a vectored immunoprophylaxis experimentCosts versus benefits: best possible and best practical treatment regimens for HIVHTLV-I infection: A dynamic struggle between viral persistence and host immunityDynamics of a stochastic cell-to-cell HIV-1 model with distributed delayUnderstanding drug resistance for monotherapy treatment of HIV infectionThe differential equation model of pathogenesis of Kawasaki disease with theoretical analysisMathematical model of an antiretroviral therapy to HIV via Filippov theoryHopf bifurcation of an age-structured virus infection modelComparison of three kinetic models of HIV-1 infection: implications for optimization of treatmentDynamics of an HIV infection model with two infection routes and evolutionary competition between two viral strainsDynamics of cytotoxic T-lymphocytes and helper cells in human immunodeficiency virus infection with Hill-type infection rate and sigmoidal CTL expansionUnnamed ItemThe work of Glenn F. WebbGlobal stability of an age-structured virus dynamics model with Beddington-DeAngelis infection functionA numerical method for the solutions of the HIV infection model of CD4+T-cellsA mathematical model for chronic myelogenous leukemia (CML) and T cell interactionOptimizing within-host viral fitness: infected cell lifespan and virion production rateAsymptotic Analysis of an Age-Structured HIV Infection Model with Logistic Target-Cell Growth and Two Infecting RoutesModelling the role of tax expression in HTLV-I persistence in vivoDrug-sparing regimens for HIV combination therapy: Benefits predicted for ``drug coastingGlobal analysis of the dynamics of a mathematical model to intermittent HIV treatmentWhat explains the poor contraction of the viral load during paediatric HIV infection?Age-Structured Within-Host HIV Dynamics with Multiple Target CellsMathematical Modeling of HIV-1 Infection and Drug TherapyGlobal properties of a delayed HIV infection model with CTL immune responseAn age-structured model with immune response of HIV infection: modeling and optimal control approachA controlled treatment strategy applied to HIV immunology modelTime periodic reaction-diffusion equations for modeling 2-LTR dynamics in HIV-infected patientsModeling within-host HIV-1 dynamics and the evolution of drug resistance: trade-offs between viral enzyme function and drug susceptibilityA model of HIV-1 pathogenesis that includes an intracellular delayHIV-1 POPULATION DYNAMICSIN VIVO: IMPLICATIONS FOR PATHOGENESIS, EFFECT OF CYTOKINE AND THERAPY STRATEGYHOW SELF-PROLIFERATION OF CD4+T CELLS AFFECT THE HIV DYNAMICS IN AN IN-HOST TARGET-CELL LIMITED HIV MODEL WITH SATURATION INFECTION RATE: A QUASI-STEADY-STATE APPROXIMATION ANALYSISAnalyzing transmission dynamics of cholera with public health interventionsNonautonomous Dynamical Systems in the Life SciencesAnalysis of a stochastic HIV-1 infection model with degenerate diffusionA mathematical model of HIV infection: Simulating T4, T8 macrophages, antibody, and virus via specific anti-HIV response in the presence of adaptation and tropismOscillatory viral dynamics in a delayed HIV pathogenesis modelA mathematical model of HIV-1 infection including the saturation effect of healthy cell proliferationThe effect of vaccination to dendritic cell and immune cell interaction in HIV disease progressionModeling intracellular delay in within-host HIV dynamics under conditioning of drugs of abuseA multi-scale mathematical modeling framework to investigate anti-viral therapeutic opportunities in targeting HIV-1 accessory proteinsAnalysis and computation of multi-pathways and multi-delays HIV-1 infection modelSome state space models of HIV pathogenesis under treatment by anti-viral drugs in HIV-infected individualsDynamics of co-infection with M. tuberculosis and HIV-1Post-transplantation dynamics of the immune response to chronic myelogenous leukemiaOptimal treatment in a multi-strain within-host model of HIV with age structureA delay-differential equation model of HIV infection of \(\text{CD}4^+\) T-cellsMathematical analysis of multi-target cells and multi-strain age-structured model with two HIV infection routesThe age-dependent population model: numerical check of stability/instability of a steady state.Optimal control in a multi-pathways HIV-1 infection model: a comparison between mono-drug and multi-drug therapiesA numerical efficient splitting method for the solution of HIV time periodic reaction-diffusion model having spatial heterogeneity


Uses Software


Cites Work